Edentulous Sites Augmented With Collagen Matrix or CTG
Primary Purpose
Edentulous Alveolar Ridge
Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Soft tissue augmentation with subepithelial connective tissue graft (SCTG)
Soft tissue augmentation with xenogenic volume stable collagen matrix
Sponsored by
About this trial
This is an interventional treatment trial for Edentulous Alveolar Ridge
Eligibility Criteria
Inclusion Criteria:
- Intercalated mono-edentulous area ridge defects to be rehabilitated with fixed partial bridge
- At least 18 years old
- At least 6 months from tooth extraction at the study area.
Exclusion Criteria:
- Systemic diseases which could influence the outcome of the therapy (e.g. uncontrolled diabetes mellitus);
- Smoking ≥ 10 cigarettes a day;
- Pregnant or nursing women;
- Chronic use of corticosteroids or other anti-inflammatory or immune-modulator drugs;
- Patients who need use of medications affecting bone metabolism or oral mucosa;
- Presence of a congruous FDP at the edentulous area;
- History of soft tissue augmentation surgery in the study area;
- Active periodontitis
- Uncompliant patients
Sites / Locations
- University of TurinRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Subepithelial Connective Tissue Graft (SCTG)
Volume Stable Collagen Matrix (VCMX)
Arm Description
Soft tissue augmentation at edentulous area with subepithelial connective tissue graft harvested from the patient's palate
Soft tissue augmentation at edentulous area with xenogenic volume stable collagen matrix
Outcomes
Primary Outcome Measures
Volumetric buccal soft tissue changes (-5 to +5 mm with positive values representing an increase in volume)
Mean linear change in mm from baseline to 6 months follow-up
Secondary Outcome Measures
Change in Probing Pocket Depth (PD) at adjacent teeth (0-15 mm with higher values representing worse outcomes)
The distance between cementoenamel junction (CEJ) and the base of the pocket
Mucosal recession at adjacent sites (0-15 mm with higher values indicating worse outcomes)
The distance between the cementoenamel junction (CEJ) and the mucosal margin
Pain (VAS scale)(0-10 with higher values indicating worse outcomes)
Subjective pain experienced by the patient expressed in a VAS scale
Full Information
NCT ID
NCT04915677
First Posted
May 25, 2021
Last Updated
February 10, 2023
Sponsor
University of Turin, Italy
1. Study Identification
Unique Protocol Identification Number
NCT04915677
Brief Title
Edentulous Sites Augmented With Collagen Matrix or CTG
Official Title
Volumetric Changes at Edentulous Sites Augmented With Collagen Matrix or Connective Tissue Graft: a Randomized Clinical Trial With 6 Months Follow up
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 10, 2021 (Actual)
Primary Completion Date
June 10, 2023 (Anticipated)
Study Completion Date
March 10, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Turin, Italy
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Ridge deformities can complicate prosthetic rehabilitation, especially in situations where optimal esthetic outcomes are desired. Simpler, less invasive and predictable treatments are needed in order to obtain soft tissue augmentation at edentulous ridges. Autogenous subepithelial connective tissue graft (SCTG) has always been regarded as the treatment of choice, but heterologous volume stable collagen matrix (VCMX) is emerging as a reliable alternative. The principal aim of the present RCT will be to compare the volumetric buccal soft tissue changes at edentulous areas after augmentation procedure using VCMX or SCTG. Parameters related to periodontal health at adjacent teeth and patient reported outcomes (PROMs) will be also assessed as secondary outcomes. Proving the non- inferiority of VCMX compared to SCTG would provide the specialists and general clinicians with an easier, less invasive and better tolerated technique for soft tissue augmentation at edentulous ridges and for improving aesthetic and cleansability of the prosthetic rehabilitation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Edentulous Alveolar Ridge
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
28 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Subepithelial Connective Tissue Graft (SCTG)
Arm Type
Active Comparator
Arm Description
Soft tissue augmentation at edentulous area with subepithelial connective tissue graft harvested from the patient's palate
Arm Title
Volume Stable Collagen Matrix (VCMX)
Arm Type
Experimental
Arm Description
Soft tissue augmentation at edentulous area with xenogenic volume stable collagen matrix
Intervention Type
Procedure
Intervention Name(s)
Soft tissue augmentation with subepithelial connective tissue graft (SCTG)
Intervention Description
After local anesthesia a mesio-distal crestal incision will be performed reaching the alveolar bone. Split thickness dissection performed both buccal and palatal. Subepithelial connective tissue graft will be harvested and inserted beneath the mucoperiosteal flap and stretched buccally and lingually using a modified horizontal mattress suture. The flap margins at the crest will be adapted using single interrupted sutures in order to achieve a primary closure of the flap.
Intervention Type
Procedure
Intervention Name(s)
Soft tissue augmentation with xenogenic volume stable collagen matrix
Intervention Description
After local anesthesia a mesio-distal crestal incision will be performed reaching the alveolar bone. Split thickness dissection performed both buccal and palatal. Xenogenic volume stable collagen matrix will be inserted beneath the mucoperiosteal flap and stretched buccally and lingually using a modified horizontal mattress suture. The flap margins at the crest will be adapted using single interrupted sutures in order to achieve a primary closure of the flap.
Primary Outcome Measure Information:
Title
Volumetric buccal soft tissue changes (-5 to +5 mm with positive values representing an increase in volume)
Description
Mean linear change in mm from baseline to 6 months follow-up
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change in Probing Pocket Depth (PD) at adjacent teeth (0-15 mm with higher values representing worse outcomes)
Description
The distance between cementoenamel junction (CEJ) and the base of the pocket
Time Frame
6 months
Title
Mucosal recession at adjacent sites (0-15 mm with higher values indicating worse outcomes)
Description
The distance between the cementoenamel junction (CEJ) and the mucosal margin
Time Frame
6 months
Title
Pain (VAS scale)(0-10 with higher values indicating worse outcomes)
Description
Subjective pain experienced by the patient expressed in a VAS scale
Time Frame
2 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Intercalated mono-edentulous area ridge defects to be rehabilitated with fixed partial bridge
At least 18 years old
At least 6 months from tooth extraction at the study area.
Exclusion Criteria:
Systemic diseases which could influence the outcome of the therapy (e.g. uncontrolled diabetes mellitus);
Smoking ≥ 10 cigarettes a day;
Pregnant or nursing women;
Chronic use of corticosteroids or other anti-inflammatory or immune-modulator drugs;
Patients who need use of medications affecting bone metabolism or oral mucosa;
Presence of a congruous FDP at the edentulous area;
History of soft tissue augmentation surgery in the study area;
Active periodontitis
Uncompliant patients
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mario Aimetti
Phone
00390116331546
Email
mario.aimetti@unito.it
Facility Information:
Facility Name
University of Turin
City
Turin
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Giacomo Baima, DDS
Phone
00393497254708
Email
giacomo.baima@unito.it
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Edentulous Sites Augmented With Collagen Matrix or CTG
We'll reach out to this number within 24 hrs